机译:Fulminant Type 1 Diabetes Mellitus Developed about Half a Year after Discontinuation of Immune Checkpoint Inhibitor Combination Therapy with Nivolumab and Ipilimumab: A Case Report
Natl Hosp Org Sendai Med Ctr, Dept Endocrinol & Metab, Sendai, Miyagi, Japan;
Tohoku Univ, Dept Endocrinol & Appl Med Sci, Grad Sch Med, Sendai, Miyagi, Japan;
diabetic ketoacidosis; fulminant type 1 diabetes mellitus; immune checkpoint inhibitor; ipilimumab; mvolumab;